FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387207048> ?p ?o ?g. }

• W4387207048 endingPage "e669" @default.
• W4387207048 startingPage "e668" @default.
• W4387207048 abstract "To characterize the tracking capability and dosimetric accuracy of biology-guided radiotherapy (BgRT) under clinically relevant PET tracer uptake scenarios relative to the background.A custom-made anthropomorphic phantom filled with a liquid 18F-FDG solution including two embedded fillable 22 mm diameter spherical structures mimicking GTV (= CTV) and OAR was coupled to motion stages to create an independent 3D respiratory motion with 22 mm maximum range for target and a 5 mm 1D sinusoidal motion in the OAR. The biology-tracking zone (BTZ) was generated by adding 5 mm margin to the motion extent. The three BgRT scenarios studied were representative of tumors with good (8:1), borderline (4:1) and undesired (2:1) PET biodistributions compared to background. The clinical safety limit of BgRT uses Activity Concentration within the BTZ (AC ≥ 5 kBq/ml) and Normalized Target Signal as a contrast metric (NTS ≧ 2.7 for planning and ≧ 2 for delivery). The BgRT deliveries were repeated 3 times with radiochromic film and integrated ion chamber capturing the target and OAR doses. Tracked dosimetry was assessed using a margin-loss calculation defined as the maximum linear difference in distance between the planned and delivered 97% prescription iso-dose lines.The imaging-only PET images used to create BgRT plans had an AC of 7.0, 5.3, and 1.6 kBq/ml with an NTS of 6.8, 5.3, and 1.8 for 8:1, 4:1, and 2:1 concentrations, respectively. Qualitatively, the target was not visible on the planning PET images 2:1 loading scenario. At delivery, the mean pre-scan activity concentrations were 6.8, 4.7, and 3.7 kBq/ml with corresponding mean NTS of 3.7, 2.6, 1.5 for 8:1, 4:1 and 2:1 deliveries. The pre-scan values of AC or NTS did not satisfy the clinical system safety limits for 4:1 and 2:1 ratio experiments, but the engineering software allowed for the delivery to capture the resulting doses. The deliveries showed a prescription dose coverage to the CTV of 100% for the 8:1 and 4:1 cases, but 88% for the 2:1 case. When compared to the planned dose values, the delivered minimum doses were -7.6%, -8.6% and -10.9%, whereas the maximum dose differences in CTV were 1.2%, 0% and -4.8% of the planned dose distributions of the 8:1, 4:1 and 2:1 cases, respectively. Calculated margin losses were -2.3, -3.8, and -5.5 mm, for the 8:1, 4:1, and 2:1 cases, respectively. The maximum OAR doses were less than the maximum doses predicted on the bounded DVH curves for all scenarios.With sufficient tracer uptake in the target, BgRT can deliver tracked dosimetry for targets with a large respiratory motion profile. Both the good BgRT candidate and borderline cases produced clinically acceptable delivered doses, even though the borderline case was flagged by the clinical system safety checks. As expected, the delivered BgRT dose distributions were suboptimal with reduced tumor over background PET contrast." @default.
• W4387207048 created "2023-09-30" @default.
• W4387207048 creator A5003106189 @default.
• W4387207048 creator A5012888192 @default.
• W4387207048 creator A5018248168 @default.
• W4387207048 creator A5021684053 @default.
• W4387207048 creator A5022843473 @default.
• W4387207048 creator A5025532740 @default.
• W4387207048 creator A5027893916 @default.
• W4387207048 creator A5029952349 @default.
• W4387207048 creator A5031290100 @default.
• W4387207048 creator A5039318031 @default.
• W4387207048 creator A5039408451 @default.
• W4387207048 creator A5050255780 @default.
• W4387207048 creator A5070481474 @default.
• W4387207048 creator A5074985368 @default.
• W4387207048 creator A5077587448 @default.
• W4387207048 creator A5077820779 @default.
• W4387207048 creator A5079499089 @default.
• W4387207048 date "2023-10-01" @default.
• W4387207048 modified "2023-10-04" @default.
• W4387207048 title "Characterization of Biology-Guided Radiotherapy Accuracy as a Function of PET Tracer Uptake" @default.
• W4387207048 doi "https://doi.org/10.1016/j.ijrobp.2023.06.2113" @default.
• W4387207048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37785972" @default.
• W4387207048 hasPublicationYear "2023" @default.
• W4387207048 type Work @default.
• W4387207048 citedByCount "0" @default.
• W4387207048 crossrefType "journal-article" @default.
• W4387207048 hasAuthorship W4387207048A5003106189 @default.
• W4387207048 hasAuthorship W4387207048A5012888192 @default.
• W4387207048 hasAuthorship W4387207048A5018248168 @default.
• W4387207048 hasAuthorship W4387207048A5021684053 @default.
• W4387207048 hasAuthorship W4387207048A5022843473 @default.
• W4387207048 hasAuthorship W4387207048A5025532740 @default.
• W4387207048 hasAuthorship W4387207048A5027893916 @default.
• W4387207048 hasAuthorship W4387207048A5029952349 @default.
• W4387207048 hasAuthorship W4387207048A5031290100 @default.
• W4387207048 hasAuthorship W4387207048A5039318031 @default.
• W4387207048 hasAuthorship W4387207048A5039408451 @default.
• W4387207048 hasAuthorship W4387207048A5050255780 @default.
• W4387207048 hasAuthorship W4387207048A5070481474 @default.
• W4387207048 hasAuthorship W4387207048A5074985368 @default.
• W4387207048 hasAuthorship W4387207048A5077587448 @default.
• W4387207048 hasAuthorship W4387207048A5077820779 @default.
• W4387207048 hasAuthorship W4387207048A5079499089 @default.
• W4387207048 hasConcept C104293457 @default.
• W4387207048 hasConcept C119857082 @default.
• W4387207048 hasConcept C126838900 @default.
• W4387207048 hasConcept C136229726 @default.
• W4387207048 hasConcept C15744967 @default.
• W4387207048 hasConcept C19417346 @default.
• W4387207048 hasConcept C201645570 @default.
• W4387207048 hasConcept C2775842073 @default.
• W4387207048 hasConcept C2775936607 @default.
• W4387207048 hasConcept C2989005 @default.
• W4387207048 hasConcept C3017724952 @default.
• W4387207048 hasConcept C41008148 @default.
• W4387207048 hasConcept C509974204 @default.
• W4387207048 hasConcept C71924100 @default.
• W4387207048 hasConcept C75088862 @default.
• W4387207048 hasConcept C774472 @default.
• W4387207048 hasConceptScore W4387207048C104293457 @default.
• W4387207048 hasConceptScore W4387207048C119857082 @default.
• W4387207048 hasConceptScore W4387207048C126838900 @default.
• W4387207048 hasConceptScore W4387207048C136229726 @default.
• W4387207048 hasConceptScore W4387207048C15744967 @default.
• W4387207048 hasConceptScore W4387207048C19417346 @default.
• W4387207048 hasConceptScore W4387207048C201645570 @default.
• W4387207048 hasConceptScore W4387207048C2775842073 @default.
• W4387207048 hasConceptScore W4387207048C2775936607 @default.
• W4387207048 hasConceptScore W4387207048C2989005 @default.
• W4387207048 hasConceptScore W4387207048C3017724952 @default.
• W4387207048 hasConceptScore W4387207048C41008148 @default.
• W4387207048 hasConceptScore W4387207048C509974204 @default.
• W4387207048 hasConceptScore W4387207048C71924100 @default.
• W4387207048 hasConceptScore W4387207048C75088862 @default.
• W4387207048 hasConceptScore W4387207048C774472 @default.
• W4387207048 hasIssue "2" @default.
• W4387207048 hasLocation W43872070481 @default.
• W4387207048 hasLocation W43872070482 @default.
• W4387207048 hasOpenAccess W4387207048 @default.
• W4387207048 hasPrimaryLocation W43872070481 @default.
• W4387207048 hasRelatedWork W2004886510 @default.
• W4387207048 hasRelatedWork W2063470859 @default.
• W4387207048 hasRelatedWork W2089785835 @default.
• W4387207048 hasRelatedWork W2091608216 @default.
• W4387207048 hasRelatedWork W2160472702 @default.
• W4387207048 hasRelatedWork W2386428293 @default.
• W4387207048 hasRelatedWork W2402643636 @default.
• W4387207048 hasRelatedWork W2593832489 @default.
• W4387207048 hasRelatedWork W2623028864 @default.
• W4387207048 hasRelatedWork W2181587534 @default.
• W4387207048 hasVolume "117" @default.
• W4387207048 isParatext "false" @default.
• W4387207048 isRetracted "false" @default.
• W4387207048 workType "article" @default.